Innoviva, Inc. — Director's Dealing 2015

May 22, 2015

SEC Form 4/A — Form 4/A

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2015-02-20

Reporting Person: Aguiar Michael W (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-20	Common Stock	F	6789	$18.22	Disposed	458107	Direct

Footnotes

F1: These shares were previously reported on the initial Form 4 filed on February 24, 2015 as being withheld by the Company to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

F2: The initial Form 4 filed on February 24, 2015 by the Reporting Person inadvertently listed the incorrect number of shares beneficially owned following the reported transaction.